← FDA DRUG APPROVALS

FDA ANDA · ANDA090978

LANTHANUM CARBONATE

Sponsor: NATCO PHARMA LTD

APPLICATION
ANDA090978
TYPE
ANDA
ORIGINAL APPROVAL
2017-08-11
LATEST ACTION
2022-07-20
ROUTE
ORAL
DOSAGE FORM
TABLET, CHEWABLE
MARKETING STATUS
Prescription

Products

LANTHANUM CARBONATEPrescription
LANTHANUM CARBONATE EQ 750MG BASE · TABLET, CHEWABLE · ORAL
LANTHANUM CARBONATEPrescription
LANTHANUM CARBONATE EQ 1GM BASE · TABLET, CHEWABLE · ORAL
LANTHANUM CARBONATEPrescription
LANTHANUM CARBONATE EQ 500MG BASE · TABLET, CHEWABLE · ORAL

Approval history

2022-07-20Labeling · Supplement 3 · standardAP
2022-07-20Labeling · Supplement 6 · standardAP
2017-08-11OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →